Hypertension may predict dementia in older adults with particular cognitive deficits

February, 2010

A large five-year study concludes that late-life hypertension doubles the risk of dementia in those with executive dysfunction only (but not for those with memory dysfunction alone or memory and executive dysfunction).

Midlife hypertension has been confirmed as a risk factor for the development of dementia in late life, but there have been conflicting findings about the role of late-life hypertension. Now a five-year study involving 990 older adults (average age 83) with cognitive impairment but no dementia, has found that dementia developed at around the same rate among participants with and without hypertension, among those with memory dysfunction alone and those with both memory and executive dysfunction. However, among patients with executive dysfunction only, presence of hypertension was associated with double the risk of developing dementia (57.7 percent of those with high blood pressure progressed to dementia, vs. 28 percent of those without). The findings suggest that efforts to control to hypertension should be especially targeted to this group.

http://www.eurekalert.org/pub_releases/2010-02/jaaj-hmp020410.php

Reference:

[178] Oveisgharan, S., & Hachinski V.
(2010). Hypertension, Executive Dysfunction, and Progression to Dementia: The Canadian Study of Health and Aging.
Arch Neurol. 67(2), 187 - 192.

seniors

alzheimers hypertension

Alzheimers

Related News

Controlling diabetes important for slowing cognitive decline

The latest finding from the large, long-running Health, Aging, and Body Composition (Health ABC) Study adds to the evidence that preventing or controlling diabetes helps prevent age-related cognitive decline.

Benefits of omega-3 in preventing age-related cognitive decline not proven

A review of three high quality trials comparing the putative benefits of omega-3 fatty acids for preventing age-related cognitive decline, has concluded that there is no evidence that taking fish oil supplements helps fight cognitive decline.

Alzheimer's risk gene disrupts brain function in older women, but not men

While the ‘Alzheimer’s gene’ is relatively common — the ApoE4 mutation is present in around 15% of the population — having two copies of the mutation is, thankfully, much rarer, at around 2%.

Brief questionnaire for dementia progression validated

Dementia is a progressive illness, and its behavioral and psychological symptoms are, for caregivers, the most difficult symptoms to manage.

Exercise reduces Alzheimer's damage in brain

A study designed to compare the relative benefits of exercise and diet control on Alzheimer’s pathology and cognitive performance has revealed that while both are beneficial, exercise is of greater benefit in reducing Alzheimer’s pathology and cognitive impairment.

Rapamycin makes young mice learn better and prevents decline in old mice

I have reported previously on research suggesting that rapamycin, a bacterial product first isolated from soil on Easter Island and used to help transplant patients prevent organ rejection, might improve learning and memory.

Coffee helps prevent progression to dementia

Following on from mouse studies, a human study has investigated whether caffeine can help prevent older adults with mild cognitive impairment from progressing to dementia.

Alzheimer’s biomarkers present decades before symptoms

A study involving those with a strong genetic risk of developing Alzheimer’s has found that the first signs of the disease can be detected 25 years before symptoms are evident.

Immune system may protect against Alzheimer's

A number of studies have come out in recent years linking age-related cognitive decline and dementia risk to inflammation and infection (put inflammation into the “Search this site” box at the top of the page and you’ll see what I mean). New research suggests one important mechanism.

Effect of blood pressure on the aging brain depends on genetics

I’ve reported before on the evidence suggesting that carriers of the ‘Alzheimer’s gene’, APOE4, tend to have smaller brain volumes and perform worse on cognitive tests, despite being cognitively ‘normal’.

Pages